NCT00770497 - Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients. | Biotech Hunter

Enrollment

172

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

InflammationHypertension

Interventions

DRUG

Pioglitazone

"Pioglitazone 15 mg, tablets, orally, once daily and ramipril placebo-matching tablets, orally, once daily for two weeks; increased to:~Pioglitazone 30 mg, tablets, orally, once daily and ramipril placebo-matching tablets, orally, once daily for up to 10 weeks."

DRUG

Pioglitazone and ramipril

"Pioglitazone 15 mg, tablets, orally, once daily and ramipril 2.5 mg, tablets, orally, once daily for two weeks; increased to:~Pioglitazone 30 mg, tablets, orally, once daily and ramipril 5 mg, tablets, orally, once daily for up to 10 weeks."

DRUG

Ramipril

"Pioglitazone placebo-matching tablets, orally, once daily and ramipril 2.5 mg, tablets, orally, once daily for two weeks; increased to:~Pioglitazone placebo-matching tablets, orally, once daily and ramipril 5 mg, tablets, orally, once daily for up to 10 weeks."

Trial Locations (13)

Unknown

Deggingen

Rottweil

Spaichingen

Weilersbach

Hanover

Cologne

Essen

Werne

Mainz

Schauenburg

Dresden

Berlin

Blankenhain